305 related articles for article (PubMed ID: 26686309)
1. Once versus twice daily injection of enoxaparin for thromboprophylaxis in bariatric surgery: effects on antifactor Xa activity and procoagulant microparticles. A randomized controlled study.
Steib A; Degirmenci SE; Junke E; Asehnoune K; Figier M; Pericard C; Rohr S; Letessier E; Brunaud L; Vix M; Zobairi F; Grunebaum L; Toti F
Surg Obes Relat Dis; 2016; 12(3):613-621. PubMed ID: 26686309
[TBL] [Abstract][Full Text] [Related]
2. The EFFORT trial: Preoperative enoxaparin versus postoperative fondaparinux for thromboprophylaxis in bariatric surgical patients: a randomized double-blind pilot trial.
Steele KE; Canner J; Prokopowicz G; Verde F; Beselman A; Wyse R; Chen J; Streiff M; Magnuson T; Lidor A; Schweitzer M
Surg Obes Relat Dis; 2015; 11(3):672-83. PubMed ID: 25620436
[TBL] [Abstract][Full Text] [Related]
3. Enoxaparin thromboprophylaxis in gastric bypass patients: extended duration, dose stratification, and antifactor Xa activity.
Borkgren-Okonek MJ; Hart RW; Pantano JE; Rantis PC; Guske PJ; Kane JM; Gordon N; Sambol NC
Surg Obes Relat Dis; 2008; 4(5):625-31. PubMed ID: 18261965
[TBL] [Abstract][Full Text] [Related]
4. Use of Enoxaparin in Obese Adolescents During Bariatric Surgery--a Pilot Study.
Mushtaq A; Vaughns JD; Ziesenitz VC; Nadler EP; van den Anker JN
Obes Surg; 2015 Oct; 25(10):1869-74. PubMed ID: 25716128
[TBL] [Abstract][Full Text] [Related]
5. Monitoring Enoxaparin with Antifactor Xa Levels in Obese Patients.
Lee YR; Vega JA; Duong HN; Ballew A
Pharmacotherapy; 2015 Nov; 35(11):1007-15. PubMed ID: 26598093
[TBL] [Abstract][Full Text] [Related]
6. Fixed-dose enoxaparin after bariatric surgery: the influence of body weight on peak anti-Xa levels.
Celik F; Huitema AD; Hooijberg JH; van de Laar AW; Brandjes DP; Gerdes VE
Obes Surg; 2015 Apr; 25(4):628-34. PubMed ID: 25223871
[TBL] [Abstract][Full Text] [Related]
7. Association Between Enoxaparin Dosage Adjusted by Anti-Factor Xa Trough Level and Clinically Evident Venous Thromboembolism After Trauma.
Ko A; Harada MY; Barmparas G; Chung K; Mason R; Yim DA; Dhillon N; Margulies DR; Gewertz BL; Ley EJ
JAMA Surg; 2016 Nov; 151(11):1006-1013. PubMed ID: 27383732
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic Use of Enoxaparin in Adolescents During Bariatric Surgery-a Prospective Clinical Study.
Vaughns JD; Ziesenitz VC; Williams EF; Nadler EP; Mikus G; van den Anker J
Obes Surg; 2020 Jan; 30(1):63-68. PubMed ID: 31463801
[TBL] [Abstract][Full Text] [Related]
9. Implementation of an enoxaparin protocol for venous thromboembolism prophylaxis in obese surgical intensive care unit patients.
Ludwig KP; Simons HJ; Mone M; Barton RG; Kimball EJ
Ann Pharmacother; 2011 Nov; 45(11):1356-62. PubMed ID: 22009998
[TBL] [Abstract][Full Text] [Related]
10. Enoxaparin dose adjustment is associated with low incidence of venous thromboembolic events in acute burn patients.
Lin H; Faraklas I; Saffle J; Cochran A
J Trauma; 2011 Dec; 71(6):1557-61. PubMed ID: 22027887
[TBL] [Abstract][Full Text] [Related]
11. Assessment of Anti-Factor Xa Levels of Patients Undergoing Colorectal Surgery Given Once-Daily Enoxaparin Prophylaxis: A Clinical Study Examining Enoxaparin Pharmacokinetics.
Pannucci CJ; Fleming KI; Bertolaccini CB; Prazak AM; Huang LC; Pickron TB
JAMA Surg; 2019 Aug; 154(8):697-704. PubMed ID: 31116389
[TBL] [Abstract][Full Text] [Related]
12. Twice-Daily Enoxaparin among Plastic Surgery Inpatients: An Examination of Pharmacodynamics, 90-Day Venous Thromboembolism, and 90-Day Bleeding.
Pannucci CJ; Fleming KI; Momeni A; Prazak AM; Agarwal J; Rockwell WB
Plast Reconstr Surg; 2018 Jun; 141(6):1580-1590. PubMed ID: 29608533
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of edoxaban, an oral factor Xa inhibitor, versus enoxaparin for thromboprophylaxis after total knee arthroplasty: the STARS E-3 trial.
Fuji T; Wang CJ; Fujita S; Kawai Y; Nakamura M; Kimura T; Ibusuki K; Ushida H; Abe K; Tachibana S
Thromb Res; 2014 Dec; 134(6):1198-204. PubMed ID: 25294589
[TBL] [Abstract][Full Text] [Related]
14. Anti-factor Xa levels in patients undergoing laparoscopic sleeve gastrectomy: 2 different dosing regimens of enoxaparin.
Gelikas S; Eldar SM; Lahat G
Surg Obes Relat Dis; 2017 Oct; 13(10):1753-1759. PubMed ID: 28918992
[TBL] [Abstract][Full Text] [Related]
15. Association of Anti-Factor Xa-Guided Dosing of Enoxaparin With Venous Thromboembolism After Trauma.
Karcutskie CA; Dharmaraja A; Patel J; Eidelson SA; Padiadpu AB; Martin AG; Lama G; Lineen EB; Namias N; Schulman CI; Proctor KG
JAMA Surg; 2018 Feb; 153(2):144-149. PubMed ID: 29071333
[TBL] [Abstract][Full Text] [Related]
16. Weight-Based Dosing for Once-Daily Enoxaparin Cannot Provide Adequate Anticoagulation for Venous Thromboembolism Prophylaxis.
Pannucci CJ; Hunt MM; Fleming KI; Prazak AM
Plast Reconstr Surg; 2017 Oct; 140(4):815-822. PubMed ID: 28953735
[TBL] [Abstract][Full Text] [Related]
17. Enoxaparin and antifactor Xa levels in acute burn patients.
Lin H; Faraklas I; Cochran A; Saffle J
J Burn Care Res; 2011; 32(1):1-5. PubMed ID: 21124231
[TBL] [Abstract][Full Text] [Related]
18. Prospective Evaluation of Weight-Based Prophylactic Enoxaparin Dosing in Critically Ill Trauma Patients: Adequacy of AntiXa Levels Is Improved.
Nunez JM; Becher RD; Rebo GJ; Farrah JP; Borgerding EM; Stirparo JJ; Lauer C; Kilgo P; Miller PR
Am Surg; 2015 Jun; 81(6):605-9. PubMed ID: 26031274
[TBL] [Abstract][Full Text] [Related]
19. Retrospective analysis of 3 different antithrombotic prophylaxis regimens in bariatric surgery.
Javanainen MH; Scheinin T; Mustonen H; Leivonen M
Surg Obes Relat Dis; 2016; 12(3):675-680. PubMed ID: 27050402
[TBL] [Abstract][Full Text] [Related]
20. Adjusted value of thromboprophylaxis in hospitalized obese patients: A comparative study of two regimens of enoxaparin: The ITOHENOX study.
Miranda S; Le Cam-Duchez V; Benichou J; Donnadieu N; Barbay V; Le Besnerais M; Delmas FX; Cuvelier A; Lévesque H; Benhamou Y; Armengol G
Thromb Res; 2017 Jul; 155():1-5. PubMed ID: 28460259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
